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Abstract 
The insurance industry in Finland is making a shift towards providing proactive healthcare 
services. Increasing availability of health data can provide means for creating personalized 
healthcare services. However, insurance companies are facing obstacles to access health data. 
This paper presents a case study of a large Finnish insurance company that is currently dealing 
with barriers of access during their transition to a more proactive organization. We identified 
nine barriers which fall into three categories – institutional, legislation, and use and 
participation. By identifying these barriers, we reveal critical factors for companies that seek to 
make use of their customers’ health data are likely to face. 
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1. Introduction  
As is the case with many organizations today, especially those that act within the broader 
context of healthcare, the insurance industry is facing barriers that plague their advancement 
into the digital health paradigm. Where once services being provided required face-to-face 
communication, technology has enabled a plethora of actionable choices for businesses to 
interact with their customers in a connected fashion. At the core of this interaction is data – data 
that represents a person, both as a patient and a customer. The collection of data is intrinsic to 
healthcare and is carried out through  a number of practices such as patient record keeping, 
policy demands, medical imaging, doctor notations, or prescriptions in a wide variety of 
heterogeneous formats. Furthermore, the advancement of the wellness sector represents an 
overall contribution to the vastness and complexity of health data collected through social 
media, the Internet of Things (IoT), home sensing, and  wearables. Data plays a crucial role in 
the change taking place in the healthcare and wellness ecosystems, and the role of technology 
for empowering individuals to take a more active role in their health [1]. 
Even if our aging demographics are indeed a red herring in the healthcare industry [33, 42], 
there are also several other pertinent challenges in the healthcare paradigm. The strain of 
keeping a healthcare ecosystem current with up-to-date information, combined with the 
implementation of advancements both medical and technological [7] are contributing to the 
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colossal techno-socio-economic burden bearing down on the healthcare sector. A burden which 
ultimately affects all stakeholders in the healthcare context. Originating from the efforts made 
to resolve this crisis, a paradigm shift in the healthcare industry has been gathering momentum 
for the last three decades, where a traditionally reactive healthcare system is shifting towards 
proactivity [18, 31]. Central to the aforementioned shift, we find Connected Health [5] which 
aims to empower customers with control of their wellness, medical treatments, and continuity 
of care (proactive) [38]. Which is opposed to the traditional approach of the ‘biomedical model’ 
in which a patient interacts with a healthcare professional, who is charged with diagnosing, 
treating, and managing the disease (reactive) [20, 22]. 
A similar shift is facing the insurance industry. For insurance providers, increasing costs of 
healthcare translate to increased healthcare insurance premiums [27]. Therefore, insurance 
companies have recently started to take an interest in the competitive potential of the access to 
health data. Having access to health data makes it possible to develop services that reduce the 
more traditional insurance customer needs for employing traditional healthcare services, thus 
reducing the costs the insurance companies would face. All while simultaneously increasing 
the value the insurance company can provide to their customers through improved quality of 
life. However, companies in the healthcare ecosystem, including insurance companies, are 
facing barriers towards the access of health data. Among these barriers are difficulties that arise 
from having multiple stakeholders; such as providers, payers, and manufacturers, resulting in 
data silo barriers for interoperability and regulatory pressures to maintain privacy [13]. In 
addition, the recently enacted General Data Protection Regulation (GDPR) that will be enforced 
in the European Union (EU) from May 25th of 2018, restricts the use of health data for 
companies [32, 37]. To navigate  this  access conundrum, insurance companies aim to offer 
proactive services that intend to help their customers maintain their health. In order to 
understand the challenges these companies face regarding the acquisition of health data 
required for the creation of such services, we seek to answer the following research question: 
“What are the health data access barriers in a Finnish insurance company transitioning from 
a reactive to a proactive company?” 
To answer this question, we examine health data access within the context of a Finnish 
insurance company with the aspiration to transform from a purely reactive company to a more 
proactive partner with customers. This focus intends to identify which barriers the Finnish 
insurance company will face as they traverse the shift towards the digital healthcare paradigm.  
2. Background 
In this section, we first present important definitions and outline the context for this paper. We 
then proceed to discuss why access is pivotal to how organizations can sense and respond in 
changing environments, and finally we explore examples of organizational barriers for data. 
2.1. Definitions of Health Data and Access 
The General Data Protection Regulation (GDPR) is scheduled to replace the current data 
protection from 1995, Directive 95/46/EC, in May of 2018. These data rules determine how 
personal data, including health data, can be used. Personal data is considered to be any data that 
can identify an individual and is considered a blanket term that encompasses a type of sensitive 
data that is named under ‘special categories’ in the GDPR that pertains to a person’s health. 
Data defined within the ‘special categories’ of the GDPR places stricter control over the 
processing and use of the data that falls within this category. The possibility to utilize health 
data requires the fulfilment of a set of conditions or exceptions to occur, explicit consent, or 
pre-defined processing circumstances [32]. In Act. 4 section 15 of the GDPR [32], health data 
is defined as “… personal data related to the physical or mental health of a natural person, 
including the provision of healthcare services, which reveal information about his or her health 
status.” For the purposes of this paper, this definition of health data will be used, although with 
the recognition that the generation of health data is not exclusive to a patient-clinician 
ISD2018 SWEDEN 
  
interaction, but also subject to additional veracious data sources such as fitness trackers, or even 
social media at the individual level [29].  
The concept of access for health data is a multi-faceted one which lends consideration to 
the different avenues of how access can take place. The term ‘access’ in healthcare has been 
heavily deliberated upon by researchers for over four decades [19, 28]. From the perspective of 
the customer or patient, access is regarded as “… the opportunity to identify healthcare needs, 
to seek healthcare services, to reach, to obtain or use healthcare services and to actually have 
the need for services fulfilled” [19]. However, since the purpose of this paper considers access 
to health data from the organizational perspective, the definition is everted. Organizational 
access concerns being given access to health data from the customer or other relevant 
stakeholders and managing access to existing health data.  All while allowing the customers to 
access and control their own data within the organizational context. In order to prevent 
confusion, it is pertinent to mention that the use of the terms “customer” and/or “patient” largely 
depends on the context, but both indicate the primary stakeholder. Considering healthcare data, 
the person whose data is accessed can be referred to as patient in the context of traditional 
healthcare services, but also as customer in the context of insurance business.  
2.2. Organizational Agility and Data Barriers 
Change is part of the world that we live in today. However, what the boundless sea of change 
means for an organization is a certain level of a uncertainty [11]. Planning for uncertain futures 
requires organizations to be agile in order to sense and respond to environmental changes. In a 
framework proposed by Overby et al. [25] an organization has to balance leveraging their 
capabilities to detect environmental change with their capabilities of reacting to the changes 
found. The role of Information Technology (IT) in an agile organization supports both the 
sensing and responding activities taking place. For example, an organization may sense that 
their customer’s preferences are evolving through market intelligence, and opt to respond to 
their request by developing a new service that aims to meet new customer demands, or make a 
different offer [11]. Part of this framework highlights the important role that IT plays in 
leveraging sensing and responding capabilities. However, IT can also prevent organizational 
agility through subpar management or poor investment choices. More specifically, inadequately 
designed systems  may create data silos in which accessibility and interoperability of data 
becomes challenging for different stakeholders, including customers. Thus, it illustrates the 
importance of managing IT. Including comprehensive planning to sense environmental 
changes, and respond accordingly through implementation and maintenance of IT [25]. 
Part of sensing environmental change is the utilization of organizational resources towards 
building an understanding of the landscape of transformation; an understanding which can be 
classified into barriers. In contemporary literature, when looking at barriers of access for 
healthcare, the majority of research addresses specific groupings of barriers of literal access for 
a patient in categories such as the role of ethnicity [8] or physical location [10] restricting 
access. Others, such as Janssen et al. [16], Smith and Sandberg [34], and van Panhuis et al. [26] 
systematically inform on data barriers in granular and meaningful detail.  
Table 1. Interpretive Summary of Open Data Adoption Barriers 
Category Summary of Barrier 
Concerns 




Difficulties of open data 
properties including invalid 
or missing data 
Task 
Complexity 
Practice challenges due to 
usefulness of existing open 
data 
Institutional Internal reflections of 
organizational constraints 
due to imbalances in 
perceived transparency or 
valuable-based actions 
Technical Lack of standards and 
definitions that support 
access and use of open data 
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around open data, partially 
due to culture 
Legislation Constraints and demands of 
policy for open data, 




Capabilities and willingness 
of open data users including 
a lack of incentives and 
knowledge for participation 
 
Janssen et al. [16] identified 6 overarching categories of barriers to adopt open data 
accessible to open governments (see Table 1). Delving into two of the categories; use and 
participation as a category identifies one type of barrier as the lack of knowledge of the public 
sector towards the utilization of open data. The technical category represents a barrier of poorly 
accessible data that lacked a common format that would be required for adoption in open 
government. Smith and Sandberg [34] further push the understanding of data use for innovation 
in an open government setting. They show that different phases in a service life cycle and across 
user types have varying barriers. Which in addition, corroborate some of  Janssen et al. [16] 
findings by demonstrating that one of the design phase barriers was rooted in the format of the 
data, which inhibited usage. Furthermore, they showed that during the transition phase the 
desires of open government data users to leverage data in innovate ways was hindered by data 
access practices. van Panhuis et al. [26] revealed 6 categories of public health data access 
barriers: economic, ethical, legal, motivational, political, and technical. Of them, economic, 
motivation, and technical are well-established barriers that are rooted in the comprehensive 
challenges of health information systems; however, ethical, legal, and political barriers are less 
straightforward and require a more abstract approach to manage the complexities represented 
by health data access [26]. Facilitating access to health data through electronic health records 
(EHRs) has been shown to be empowering for patients who seek advice, comfort, or 
companionship with other patients with similar diseases. One example of this can be found in 
the case of PatientsLikeMe and similar communities pertaining to amyotrophic lateral 
sclerosis (ALS) [9, 39]. Patients in these communities have shown their willingness to give 
access to their health data in a symbiotic environment.  
Previous research has addressed the question of data access barriers mainly from the 
customer or patient perspective for open or public data [16, 26]. However, research on private 
organizational access to customers’ health data is weakly represented in earlier literature. This 
gap is noteworthy, considering that access to data is a fundamental competitive advantage for 
organizations [15, 29]. This paper aims to contribute insight in this area and take a step towards 
closing this gap. 
3. Methodology 
3.1. Case Context 
This paper explores a single case study of a Finnish mutual insurance company, that we, in this 
paper, lend the moniker ‘Omega’. Traditional Finnish insurance companies were built upon 
principles established in the 18th and 19th century, reflecting the ideals surrounding social 
welfare of that time. Today, Omega is part of the oligopoly of leading insurance companies 
within Finland and aims to offer the people of Finland support and access for a safer and 
healthier life. Omega has service coverage for both business and personal purposes in: 1) life - 
people and animals, 2) non-life - travel, vehicles, accommodation, property, luggage, and legal 
expenses, and 3) pension - revenue based labour earning returns. One of Omega’s visions is to 
provide a better quality of life for their customers, and Omega is taking action by inaugurating 
the offering of holistic health, life, and security services to their customers. This vision will be 
referred to as ‘Holistic Life Insurance’ in the present paper. As part of this vision, Omega wants 
to provide more proactive services to their customers than are currently available. However, in 
order to provide these services which would be more personalized to the customer’s experience, 
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Omega seeks access to health data which allows services such as predictive analytics to be 
utilized.  
Presently, the most proactive services Omega has to offer exist within the Workplace 
Health and Safety department, where general preventative measures are taken by providing 
corporate customers with safety demonstrations through channels such as YouTube that 
establish workplace practices for safety. Another example of Omega’s movements towards a 
proactive service is the ‘digital hospital’ where customers are able to contact frontline support 
nurses through various mediums including instant chat messaging and over the phone. This 
remains a more reactive approach to healthcare as the customer has to contact Omega, but plans 
are in motion to use the digital hospital as a stepping stone towards more meaningful 
implementations of proactive services through the collection, storage, and analysis of customer 
data which would then be used for personalization of health services. The intended end result 
of these proactive, personalized health service offerings would be to create value for the users 
through reducing their need for healthcare services, which would also reduce the amount of 
medical claims paid for by Omega. Based on Omega’s vision, it is a suitable case company for 
this study.  
3.2. Data Collection 
The study was conducted as a qualitative case study. A case study is suitable when the focus of 
the research is on ‘studying a contemporary phenomenon within some real-life context’ and 
when the ‘investigator has little control over events’ [40]. As this study seeks answers to the 
contemporary phenomenon of companies wanting to make use of persons’ health data in a real-
life context (i.e., the insurance company), and as the investigators had no control over events 
transpiring in Omega, the case study is a suitable approach to answering the research question. 
Semi-structured interviews were chosen as the primary data collection method for this case 
study due to the exploratory nature of the research question. Interviews have been a long-
established tool in the Information Systems (IS) discipline for gathering qualitative data [21]. 
The semi-structured interviews designed for the case study followed the general guidelines of 
having prepared questions in advance but probing of interesting answers in an ad hoc nature 
during the interviews themselves. The core themes of the interview questions were: health data, 
organizational transformation, and value co-creation. The ten interviews took place in August 
and September of 2017. All interviews were conducted in English together with another co-
author, lasted between 60 to 90 minutes, and were conducted in person in Finland. Table 1 
below outlines the interviewee respondents, their role, and their area of expertise. The 
interviewee identifier (01-10) will be used in Section 4 in connection to direct quotations. Due 
to considerations of the native language of the interviewees not being English, the nature of 
speech to be imperfect, the goal of the research not being a discourse analysis, and wishing to 
extract meaning and perception, a denaturalized transcription process was utilized [24]. A 
denaturalized transcription ‘cleans’ the transcription whilst keeping it as close to the authentic 
interview as possible; instead the denaturalized transcript relies upon authentic representation 
by denoting meaning and perceptions of the text. A high-level analysis took place during the 
transcribing process where interesting or overlapping ideas were collected for later review. 
 
Table 2. Summary of Interviewees 
Interviewee Interviewee Position Area of Expertise 
01 Unit Director Business – Workplace Health and Safety 
02 Unit Director Business – Worker’s Compensation 
03 Development Manager Customer Experience Research 
04 Unit Director New Business Development 
05 Development Manager Digital Healthcare Services 
06 Chief Digital Officer Digital Healthcare Services 
07 Program Director Digital Healthcare Services 
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08 Communications Manager Public Relations 
09 Development Manager Corporate Business – Worker’s Compensation 
10 Development Manager Data – Business Intelligence and Analysis 
 
3.3. Data Analysis 
For the analysis of the interview data, we opted for a thematic analysis process. Which is a 
qualitative tool that, through an abstraction process, encapsulates meaning from the 
interviewees that aligns with the research purpose in order to generate an improved 
understanding of the data. To imbue rigor to the analysis process, transparency of the qualitative 
technique is important. Initially, a familiarization process of the data took place where the data 
was listened to, transcribed, and then read through. Second and third was the identification of 
key themes and typologies followed by indexing for ease of further reference and use in the 
future. Fourth, the identified themes/concepts were arranged according to the goals of this 
research and finally, they were interpreted by mapping the phenomena to offer explanations 
around the research question. No pre-defined nodes or lenses were used to identify the barrier 
themes revealed in the data. However, after identifying the barriers through the analysis process, 
we mapped them to the six categories of open data adoption identified by Janssen et al. [16]. 
Our findings fall within three of these six categories: institutional, legislation, and use and 
participation. These were supported with nine barriers in the data. We will present them below 
in more detail. 
4. Results 
The results are classified into three categories: institutional, legislation, and use and 
participation, which contain nine barriers. Table 2 summarizes our findings and classifications.  
 
Table 3. Barriers of Health Data Access 
Categories Barriers 
Institutional  • Diverging interpretation of customer’s willingness to share data 
• The perceived stigma of insurance organizations 
Legislation • Restrictive data collection and use capabilities 
• Cost of compliance  
• Internal interoperability constraints to use data  
• Safety and privacy demands 
• Different rules for insurance organizations 
Use and participation • Lack of know-how to use social media data  
• Lack of incentives for customers to share data 
 
Institutional - Part of the transition process for Omega towards becoming a more proactive 
company is being able to provide digital health services that utilize health data. Access to this 
health data require the consent of the customer towards sharing their health data. Having access 
to this data is necessary in order to provide proactive services to the customer. However, we 
found that there is something of a contradiction in how interviewees see the customers’ 
willingness to sharing health data. Across all the interviews it became quite apparent that there 
was a divergence of understanding around the customers’ attitudes for health data sharing. This 
ultimately affirmed an internal lack of understanding of the customers’ willingness to give 
Omega access to their health data. Several interviewees highlighted the customer to be quite 
conservative regarding their healthcare data: “My perception is that the average Finn is very 
scared of giving out any data at all…” 03. On the other hand, some interviewees argued in 
favour of customer willingness or compliance to share their data, as expressed by Interviewee 
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04: “(…) I have not yet seen that that the customer would say that they don't want to share the 
data.” Diverging opinions around the point-of-view of understanding the customer’s attitudes 
for health data sharing is obfuscating their organizational ability to properly understand their 
customers. Whether the customer is seen to be willing or unwilling to provide their health data 
(or less sensitive personal data) to Omega acts as a barrier for the considerations of proactive 
service implementation.  
Echoed by many of the participants was the negative affiliation insurance customers create 
during their experience with Omega. The insurance industry is subject to varying stigmas from 
customers with the current reactive model. For instance, customers contact their insurance 
providers mainly seeking compensation after an incident occurs, thus affiliating negative 
experiences. From a customer perspective, being able to trust those who will provide and 
provision for you is an implicit part of the company’s responsibility. “Somehow people trust 
doctors, and I guess some people would see that insurance experts would have more of his own 
interest [than a private sector doctor] would have. I don't know what [the truth is], but that's 
how people perceive it.” 07. This illustrates a certain level of awareness of the barrier stigma 
creates. Omega is also aware of the need to delineate how health data will be used: “We have 
to be honest to our customers, and we have to tell the reason to our customers for why we are 
collecting your data, and what is the proposed cases (in which) we are using your data. In that 
sense, transparency is the issue…” 06. 
Legislation -  There are two main types of policy that externally affect the possibilities of 
Omega to provide more proactive services to their customers due to health data access 
restrictions. The first policy is the GDPR which is a European ‘blanket’ regulation coming into 
effect in May of 2018. This regulation is aimed at improving privacy and protection for personal 
data (including health data) for all persons living within the EU [32]. All companies within the 
EU are obligated to follow the provisions set forth, but leave them open for interpretation for 
adopting and adapting the changes within an organization [37]. The GDPR affects the provision 
of proactive services in two ways. The first barrier restricts the way Omega can collect and use 
their customers’ health data. The second barrier is the burden of compliance related costs, which 
Omega would have to shift onto their customers. Half of the interviewees expressed concerns 
regarding the GDPR in terms of the financial burden it carries. From an adherence perspective, 
four interviewees indicated the influence of the GDPR towards reactive responses to adapting 
in Omega. Violation and non-adherence of the GDPR carries a hefty fine, while obliging the 
demands of the GDPR means additional costs for Omega. The implications of the costs for 
adherence (both compliance or defiance) are costs that, in turn, fall on the customer: “…GDPR, 
it is of course adding a cost (…) we will somehow have to get that back from our clients, in 
order to be able to maintain in this business and serve them.” 06. 
The second type of policy regards the legal aspects of data use at the national level; these 
regulations are authoritarian in the insurance world. The regulations prohibit the use of data 
between departments or drawing connections across customer services. In addition, the use of 
health data is also affected by the legal requirements for technical compliance for data safety 
and privacy: “There has to be taken into account quite many data safety and also those privacy 
issues.” 02. These are the third and fourth barriers. Thus, despite the capabilities of technology 
for storage, retrieval, and analysis, the policy adherence requirements challenge how Omega 
governs health data. For Omega, these regulations have implications that several respondents 
see as problematic: “I feel that the legal issue is the only real issue, in practice.” 03. 
Finland is now navigating through its second healthcare reform to make better use of health 
data. This reform has numerous social implications and ultimately impacts the workings of 
Omega as the reform incentivizes Omega to enter the healthcare ecosystem. Part of this 
healthcare reform is about societal value alignments around realizing the potential of health 
data: “… I would say that in the future, people will be even more aware of the value of this 
data.” 07. The ever-increasing awareness of the potential value of health data cultivates a 
competitive market in the insurance industry. However, the fact that Omega is an insurance 
company and not a health provider makes it subject to different rules, indicating the fifth barrier. 
These rules affect their rights to access health data. For example, as an insurance company, 
Omega is restricted from storing certain health-related data. As a result, Omega has entered 
GRUNDSTROM ET AL.  HEATH DATA ACCESS BARRIERS  
  
partnerships with pertinent facilitators to digital health services in order to circumvent the 
restrictions they face as an insurance company: “(…) [in the future we might have] our own 
company which gives healthcare services but now it's not possible because we are insurance 
company and we need partner….” 05. This is a step towards being able to provide more 
proactive services to their customers in future. 
Use and participation - In the context of access to customer data, social media is slated to 
play an important role. One requirement of a proactive organization is accurate, longitudinal 
data. Omega has an opportunity to access and gather a large amount of longitudinal personal 
data through customer social media channels. The barrier in this context is represented by the 
lack of know-how when dealing with social media data. Although Omega sees the potential in 
social media, they do not know how to utilize this data in a meaningful way. Largely, this is 
due to the insurance industry tempo for making changes as it is relatively slow: “And it's very 
easy to see that our history is affecting the pace (of which) we are adopting new things. Social 
media, among them (...)” 06. Questions of the role and potential value of social media in form 
of publicly available data has forced Omega to acknowledge the power of social media and 
consider how social media might play a role in the organization and for customer interaction. 
Now, Omega is taking a step towards engaging customers and inculcate customer experience 
using social media: “(…) [we want to] switch gears and start to somehow link it more closely 
to the customer experience, and somehow try to increase our presence and be more relevant 
for our customers [in social media].” 08. 
As earlier outlined, one critical factor in successfully traversing the proactive paradigm 
shift is having customers share their data with Omega. However, there is a barrier of 
incentivizing customers to share data. In a typical transaction, reciprocity is implied; you give 
something to get something in return. For Omega, the abstraction of insurance being able to 
give something back to the customer when they share their data is limiting how digital services 
are being created. Without the customer being willing to share the data, the service cannot be 
provided, but the situation is a catch-22 where Omega wants to provide personalized and 
proactive services but cannot until customers participate in the sharing of their data over a 
period of time: “The biggest barrier is that if they decide to share the data (…) why will people 
[put in effort] to give the data?” 04. Further issues within the context of this barrier was found 
in the respondents’ reflections on customer beliefs. The customer believes that if they do share 
their data, they will have it used against them to prevent insurance payment, or in other harmful 
ways: “(…) if they share this information, they think that they don't get the payment for 
insurance is one thing.” 10. Providing personalized services will require an imbalance that is 
reliant upon the customer to act first through data sharing.  
In summary, barriers to health data access found in this study related to the institutional, 
legislation, and use and participation categories. 
5. Discussion of Findings 
In this study, we set out to identify health data access barriers in the context of providing 
proactive digital health services in a Finnish Insurance company. The importance of 
understanding what barriers any organization is facing is crucial for organizational agility and 
management of the implications they are accompanied by [6, 25]. Since data is intrinsic to the 
operation of many organizations, awareness of what barriers affect their work is crucial for 
movements towards proactive solutions. In Omega’s business practices, health data access is 
critical to strengthen its competitive position in the overall insurance market [14]. With the 
current day Omega heading towards a company vision of 'Holistic Life Insurance’ that acts 
beyond traditional, reactive claims handling, in an effort to become a proactive ‘life partner’. 
There are health data barriers that need to be addressed to reach this vision. We discuss how 
our identified barriers affect the transition into a proactive company through implications found 
in this study, as well as possible solutions.  
The institutional category highlights diverging internal opinions to understanding the 
customer’s willingness to share data. Other studies corroborate these findings, where patients 
are less willing to share their health data with insurance organizations as they consider them to 
ISD2018 SWEDEN 
  
be non-essential health providers [4, 17]. This correlates with the second barrier where 
insurance companies are facing a constant societal stigma that paints their organizations in a 
negative light. When it comes to including customers in the processes of managing health data 
barriers, the inclusion process aims to orient a company proactively around the customer.  
Blocker et al. [7] argue that “[p]roactive customer orientation refers to a provider’s capability 
to continuously probe customers’ latent needs and uncover future needs, possibly offering ideas 
even before customers realize they had such a need; from the customer’s perspective, it reflects 
customers’ perceptions that providers have proactive processes and skills to successfully 
anticipate their latent and future needs.” This proposition goes along with building a culture of 
transparency to break down the stigma barrier, in which the inclusion of customers in the 
organizational processes improves the transparency of a company’s practices around the 
utilization of health data. Through facilitating a better relationship between the customer and 
the insurance organization. The possibilities to sense the customer’s attitudes for health data 
sharing and the possibilities to respond to those attitudes are improved accordingly. 
The legislation category brings to light health data barriers which we found to be tied to 
policy and in the context of European and National policies. These are equally relevant for other 
(insurance) companies in the EU. For Omega to transition into a more proactive organization, 
use of data derived from the healthcare context is required. Both the EU-wide GDPR, which 
causes additional costs for Omega, and the policies that restrict the access of health data despite 
its availability, weaken Omega’s possibilities for developing more proactive services from the 
customer data they have collected through various services, such as the digital hospital. The 
GDPR calls for a higher standard of data storage, protection, collection, and processing for 
every business and organization that is within or does business with the EU [36]. Since 
insurance companies are already heavily regulated in Finland, it is likely that many insurance 
companies already comply with a majority of the changes the GDPR imposes. Despite the 
concerns around the restrictions of data use from a policy perspective, which affects how 
services can be provided, one divination rings true - the customer. Since the customer has been 
empowered by laws (new and old), the restrictions of the laws can be successfully traversed as 
long as the customer gives informed general consent [23], affording companies the opportunity 
to adapt to the pressures the external barriers are creating.  
Business models are being explored in the context of emerging paradigms, such as the 
proactive paradigm, where “competition will center on personalized co‐creation experiences, 
resulting in value that is truly unique to each individual” [30].  Organizations are increasingly 
making movements towards including and engaging the customer through social media 
platforms such as Facebook and Twitter in a more meaningful way. Social media holds 
immense potential for organizations to shift away from traditional customer relationship 
management (CRM) models into a more social CRM [12] approach. The use and participation 
category highlights two barriers along this path. Organizations lacking an understanding of how 
to use social media data that is available, and how to incentivize customers to share their health 
data. It is important for organizations to understanding how customers would facilitate access, 
and if social media data is valuable for either party. Permission to collect and use social media 
data is complicated by regulation and a lack of policy for clear and concise polices that advocate 
for the use of social media that “highlight the importance of its institutionalization in 
organizations” [3]. One implication of our findings is that companies who want to make use of 
social media data should develop clear high-level policies around social media to embrace and 
exploit the collection, access, and use of social media data towards interacting with the customer 
through social platforms, and utilizing publicly available data from social media contexts [2, 
35]. Particularly for health and wellness as social influence has been shown to positively 
incentivize healthy habits such as exercising more frequently [41]. Or in cases of social 
platforms as PatientsLikeMe where patients are motivated to facilitate access to their health 
data in order to form symbiotic relationships as they perceive value in sharing actions [9, 39]. 
What is most interesting about the nine barriers that culminate in half of the specific 
categories identified by Janssen et al. [16] is how well they fit, considering this paper focuses 
on a private organization (as opposed to an public organizational setting). Omega has just 
started to sense their environmental changes, and the organization is quite slow to respond 
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(illustrated in party by the adoption rate of social media practices). As such, overcoming these 
barriers are part of the journey to transform into a more proactive organization. Furthermore, 
we discovered indications for future research to include more stakeholders towards the 
provision of a wider scope of barriers, and other meaningful insights.  
6. Conclusion 
In this paper, we asked what the health data access barriers are for digital health services in a 
Finnish insurance company that wants to transition from a reactive to a proactive service 
provider. We conducted a qualitative case study in one Finnish insurance company who seeks 
to become a proactive provider of health services and identified nine types of barriers in three 
categories: institutional, legislation, and use and participation. We discussed how and why these 
barriers are affecting the transition to a proactive paradigm. Moving forward with barrier 
management for health data will require resources in the form of experts to analyse and make 
sense out this new environment and plan how to solve the barriers identified in our study.  
We also like to acknowledge some limitations of this study, where the biggest one primarily 
relates to the case study being conducted in a single case company. By either studying additional 
insurance case companies or longitudinally extending the Omega case, we may have identified 
additional barriers that fit all six categories. Part of the reason why only three of the six 
categories were found might be due to the interviews being conducted primarily with 
management roles, which may explain why barriers in a category like technical were 
overlooked. Also, our case study specifically focused on health data which affects the 
understanding of other data types. However, looking to future research areas is axiomatical with 
the limitations of this study, where expanding the identified barriers across a wider insurance 
and data context could broaden the understanding of the contemporary barriers insurance 
companies are facing. 
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